Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lindqvist

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Molecular Genetics and Metabolism|July 14, 2022
Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter studyPaul Harmatz, Joseph Muenzer, Fatih Ezgü, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 29, 2025
A plasma protein profile of antidepressant response to omega-3 fatty acidsJesper Lindahl, Miranda Stiernborg, Filip Ventorp, et al.
Brain, Behavior, & Immunity - Health|April 13, 2026
Kynurenine pathway metabolites are increased in inflammatory depression and decrease with omega-3 treatmentJesper Lindahl, Gustav Söderberg Veibäck, Klara Suneson, et al.
Biological Psychiatry|March 10, 2009
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severityDaniel Lindqvist, Shorena Janelidze, Peter Hagell, et al.
Brain, Behavior, and Immunity|February 25, 2025
Corrigendum to "Omega-3 fatty acids for inflamed depression - A match/mismatch study" [Brain Behav. Immun. 118 (2024) 192-201]Klara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain, Behavior, and Immunity|March 3, 2024
Omega-3 fatty acids for inflamed depression - A match/mismatch studyKlara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Psychological Medicine|May 23, 2020
Pre-treatment allostatic load and metabolic dysregulation predict SSRI response in major depressive disorder: a preliminary reportChristina M Hough, F Saverio Bersani, Synthia H Mellon, et al.
Drug Discovery Today|July 14, 2015
Telomerase activation as a possible mechanism of action for psychopharmacological interventionsFrancesco S Bersani, Daniel Lindqvist, Synthia H Mellon, et al.
The Lancet Regional Health. Europe|June 9, 2025
Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trialBo Söderpalm, Helga Lidö, Johan Franck, et al.
Psychosomatic Medicine|July 1, 2016
The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 PersonsSabrina M Darrow, Josine E Verhoeven, Dóra Révész, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Molecular Genetics and Metabolism|July 14, 2022
Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter studyPaul Harmatz, Joseph Muenzer, Fatih Ezgü, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 29, 2025
A plasma protein profile of antidepressant response to omega-3 fatty acidsJesper Lindahl, Miranda Stiernborg, Filip Ventorp, et al.
Brain, Behavior, & Immunity - Health|April 13, 2026
Kynurenine pathway metabolites are increased in inflammatory depression and decrease with omega-3 treatmentJesper Lindahl, Gustav Söderberg Veibäck, Klara Suneson, et al.
Biological Psychiatry|March 10, 2009
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severityDaniel Lindqvist, Shorena Janelidze, Peter Hagell, et al.
Brain, Behavior, and Immunity|February 25, 2025
Corrigendum to "Omega-3 fatty acids for inflamed depression - A match/mismatch study" [Brain Behav. Immun. 118 (2024) 192-201]Klara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain, Behavior, and Immunity|March 3, 2024
Omega-3 fatty acids for inflamed depression - A match/mismatch studyKlara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Psychological Medicine|May 23, 2020
Pre-treatment allostatic load and metabolic dysregulation predict SSRI response in major depressive disorder: a preliminary reportChristina M Hough, F Saverio Bersani, Synthia H Mellon, et al.
Drug Discovery Today|July 14, 2015
Telomerase activation as a possible mechanism of action for psychopharmacological interventionsFrancesco S Bersani, Daniel Lindqvist, Synthia H Mellon, et al.
The Lancet Regional Health. Europe|June 9, 2025
Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trialBo Söderpalm, Helga Lidö, Johan Franck, et al.
Psychosomatic Medicine|July 1, 2016
The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 PersonsSabrina M Darrow, Josine E Verhoeven, Dóra Révész, et al.
Pageof 9